The combination of antifibrotic therapy and pulmonary vasodilator therapy improved transplant-free survival but had no ...

Cardiac output and stroke volume as measured by impedance cardiography may hold potential to predict clinical deterioration ...

Gradient Denervation Technologies, which is based in Paris, France, announced that the company’s pulmonary artery denervation ...

Immunosuppression appears to reduce mortality among people with systemic sclerosis with pulmonary arterial hypertension but ...

The following is a summary of "Prognostic value of non-invasive right ventricle-pulmonary artery coupling in patients with ...

Detailed price information for Tectonic Therapeutic Inc (TECX-Q) from The Globe and Mail including charting and trades.

Data collected on patients seen from September 1, 1996, to December 31 ... [9] Consequently, a group of pulmonary hypertension specialists initiated a voluntary collaborative survey entitled ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...

Earlier this afternoon, Gossamer Bio issued a press release announcing its first-quarter 2025 financial results and provided a corporate update. Please note that certain information discussed on the ...

The estimated domestic prevalence population is known to be about 500,000 and about 1% of the global population ... treprostinyl inhalants used for group 3 pulmonary hypertension, which are ...